WAMIF : Young Women Presenting Acute Myocardial Infarction in France (WAMIF)
Prospective Registry in Young Women Presenting Acute Myocardial Infarction in France: Clinical, Morphological and Biological Descriptive Analysis: WAMIF Study
Sponsor: Abbott Medical Devices
A NA clinical study on Acute Myocardial Infarction and Women Over 18 and Under 50 Years of Age, this trial is completed. The trial is conducted by Abbott Medical Devices and has accumulated 11 data snapshots since 2017. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.
Status Flow
Change History
11 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Mar 2024 — Jul 2024 [monthly]
Completed NA
-
Feb 2021 — Mar 2024 [monthly]
Completed NA
Status: Recruiting → Completed
-
Jan 2021 — Feb 2021 [monthly]
Recruiting NA
▶ Show 6 earlier versions
-
Jan 2020 — Jan 2021 [monthly]
Recruiting NA
-
May 2019 — Jan 2020 [monthly]
Recruiting NA
-
Dec 2018 — May 2019 [monthly]
Recruiting NA
-
Jun 2018 — Dec 2018 [monthly]
Recruiting NA
-
Sep 2017 — Jun 2018 [monthly]
Recruiting NA
-
May 2017 — Sep 2017 [monthly]
Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Abbott Medical Devices
- AstraZeneca
- Biosensors Europe SA
- Biotronik SE & Co. KG
- Boston Scientific Corporation
- Daiichi Sankyo
- French Cardiology Society
- French Federation of Cardiology
- Hexacath, France
- I.V.S. Institut des Vaisseaux et du Sang
- Terumo Corporation
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Amiens, France , Annecy, France , Antibes, France , Argenteuil, France , Avignon, France , Beauvais, France , Brest, France , Chartres, France , Clermont-Ferrand, France , Dijon, France and 14 more locations